• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞治疗:治疗子宫瘢痕和卵巢早衰的有前途的方法。

Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure.

机构信息

Department of Obstetrics, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu Province, China; Fourth Clinical Medicine College, Nanjing Medical University, Nanjing, Jiangsu Province, China.

Department of Obstetrics, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu Province, China.

出版信息

Tissue Cell. 2022 Feb;74:101676. doi: 10.1016/j.tice.2021.101676. Epub 2021 Nov 9.

DOI:10.1016/j.tice.2021.101676
PMID:34798583
Abstract

Both intrauterine adhesions (IUA) and premature ovarian failure (POF) have plagued women all over the world for a long time. It is well known that all invasive operations involving the uterus can disrupt its structural and functional integrity to a varying degree, which inevitably lead to abnormal scar formation, such as IUA, also known as Asherman's syndrome with symptoms like hypomenorrhea or infertility. Another reproductive disorder that causes infertility is primary ovarian insufficiency (POI) or POF, which is a degenerative phenomenon in the ovary among women under the age of 40. In recent years, various types of stem cells, especially mesenchymal stem cells (MSCs) have been widely used in reproductive medicine due to their properties, such as immunoregulation, anti-inflammation, angiogenesis, anti-apoptosis, and trophicity. However, the extensive clinical application of cell therapy is impeded by their safety, cost, and manufacturing. In this review, we sought to summarize the recent advances in using different types of MSCs in treating uterine scars and POF. We also describe several biological pathways and molecules involved in animal studies and clinical application; extracellular vesicles secreted by MSCs may be a promising attractive tool to ensure the treatment of infertility by restoring normal reproductive function.

摘要

宫腔粘连(IUA)和卵巢早衰(POF)长期以来一直困扰着世界各地的女性。众所周知,所有涉及子宫的侵入性手术都会在不同程度上破坏其结构和功能的完整性,这不可避免地导致异常瘢痕形成,如 IUA,也称为 Asherman 综合征,其症状包括月经过少或不孕。另一种导致不孕的生殖障碍是原发性卵巢功能不全(POI)或 POF,这是 40 岁以下女性卵巢的退行性现象。近年来,由于间充质干细胞(MSCs)等特性,如免疫调节、抗炎、血管生成、抗细胞凋亡和营养作用,各种类型的干细胞,特别是间充质干细胞(MSCs)已广泛应用于生殖医学。然而,细胞治疗的广泛临床应用受到其安全性、成本和制造的限制。在这篇综述中,我们试图总结使用不同类型的 MSCs 治疗子宫瘢痕和 POF 的最新进展。我们还描述了动物研究和临床应用中涉及的几种生物学途径和分子;MSC 分泌的细胞外囊泡可能是一种很有前途的有吸引力的工具,可通过恢复正常生殖功能来确保治疗不孕。

相似文献

1
Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure.间充质干细胞治疗:治疗子宫瘢痕和卵巢早衰的有前途的方法。
Tissue Cell. 2022 Feb;74:101676. doi: 10.1016/j.tice.2021.101676. Epub 2021 Nov 9.
2
Tracking of human embryonic stem cell-derived mesenchymal stem cells in premature ovarian failure model mice.人胚胎干细胞源性间充质干细胞在卵巢早衰模型小鼠中的示踪研究。
Biochem Biophys Res Commun. 2021 Nov 5;577:6-11. doi: 10.1016/j.bbrc.2021.08.063. Epub 2021 Aug 26.
3
Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility.间充质干细胞作为治疗女性不孕症的生物器官
Cells. 2020 Oct 8;9(10):2253. doi: 10.3390/cells9102253.
4
The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.人脐带间充质干细胞治疗卵巢早衰的治疗潜力。
Stem Cell Rev Rep. 2023 Apr;19(3):651-666. doi: 10.1007/s12015-022-10493-y. Epub 2022 Dec 15.
5
Human Umbilical Cord Mesenchymal Stem Cells Improve Ovarian Function in Chemotherapy-Induced Premature Ovarian Failure Mice Through Inhibiting Apoptosis and Inflammation via a Paracrine Mechanism.人脐带间充质干细胞通过旁分泌机制抑制细胞凋亡和炎症,改善化疗诱导的卵巢早衰小鼠的卵巢功能。
Reprod Sci. 2021 Jun;28(6):1718-1732. doi: 10.1007/s43032-021-00499-1. Epub 2021 Mar 9.
6
Effects of VEGF Mesenchymal Stem Cells and Platelet-Rich Plasma on Inbred Rat Ovarian Functions in Cyclophosphamide-Induced Premature Ovarian Insufficiency Model.血管内皮生长因子(VEGF)间充质干细胞和富血小板血浆对环磷酰胺诱导的近交系大鼠卵巢早衰模型卵巢功能的影响。
Stem Cell Rev Rep. 2019 Aug;15(4):558-573. doi: 10.1007/s12015-019-09892-5.
7
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure.骨髓间充质干细胞治疗卵巢早衰的潜力。
Stem Cell Res Ther. 2018 Oct 4;9(1):263. doi: 10.1186/s13287-018-1008-9.
8
Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.卵巢早衰:间充质干细胞的发病机制及治疗潜力
J Mol Med (Berl). 2021 May;99(5):637-650. doi: 10.1007/s00109-021-02055-5. Epub 2021 Feb 27.
9
Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure.热休克预处理间充质干细胞抑制卵巢颗粒细胞凋亡增强化疗诱导的卵巢早衰修复作用。
Stem Cell Res Ther. 2018 Sep 26;9(1):240. doi: 10.1186/s13287-018-0964-4.
10
Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure.间充质干细胞在卵巢早衰中的生物学机制及应用前景。
Medicine (Baltimore). 2022 Aug 12;101(32):e30013. doi: 10.1097/MD.0000000000030013.

引用本文的文献

1
Significance of Mitochondrial Dynamics in Reproductive Physiology: Current and Emerging Horizons in Mitochondrial Therapy for Assisted Reproductive Technologies.线粒体动力学在生殖生理学中的意义:辅助生殖技术线粒体治疗的现状与新进展
Reprod Med Biol. 2025 Aug 17;24(1):e12672. doi: 10.1002/rmb2.12672. eCollection 2025 Jan-Dec.
2
Stem cell-derived exosomes: a potential therapeutic strategy for enhancing tendon stem/progenitor cells function in tendon-bone healing.干细胞衍生的外泌体:一种增强肌腱干细胞/祖细胞在肌腱-骨愈合中功能的潜在治疗策略。
J Orthop Surg Res. 2025 Jul 15;20(1):658. doi: 10.1186/s13018-025-06060-z.
3
Exosomes derived from human amniotic mesenchymal stem cells promotes angiogenesis in hUVECs by delivering novel miRNA N-194.
源自人羊膜间充质干细胞的外泌体通过递送新型微小RNA N-194促进人脐静脉内皮细胞的血管生成。
Mol Med. 2025 May 6;31(1):173. doi: 10.1186/s10020-025-01192-8.
4
Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats.人胚胎干细胞来源的免疫与基质调节细胞促进宫腔粘连大鼠子宫内膜修复及生育力恢复
Stem Cell Res Ther. 2025 Apr 23;16(1):204. doi: 10.1186/s13287-025-04298-2.
5
Placental mesenchymal stem cell-derived exosomes treat endometrial injury in a rat model of intrauterine adhesions.胎盘间充质干细胞来源的外泌体治疗大鼠宫腔粘连模型中的子宫内膜损伤。
Mol Genet Genomics. 2025 Mar 25;300(1):36. doi: 10.1007/s00438-025-02241-x.
6
Unlocking Therapeutic Potential: Mesenchymal Stem Cells-derived Exosomes in IUA Treatment, Current Status and Perspectives.解锁治疗潜力:间充质干细胞衍生的外泌体在宫腔粘连治疗中的现状与展望
Curr Pharm Des. 2025;31(21):1663-1672. doi: 10.2174/0113816128337236241210080728.
7
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.间充质干细胞及其衍生的外泌体:治疗女性生殖功能障碍的有吸引力的治疗方法。
Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6.
8
Validity of stem cell-loaded scaffolds to facilitate endometrial regeneration and restore fertility: a systematic review and meta-analysis.干细胞负载支架促进子宫内膜再生和恢复生育能力的有效性:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 May 23;15:1397783. doi: 10.3389/fendo.2024.1397783. eCollection 2024.
9
Evaluation of the therapeutic effect of very small stem cells from peripheral blood on the treatment of Premature Ovarian Failure: A pilot study.外周血极小干/祖细胞治疗卵巢早衰的疗效评价:一项初步研究。
JBRA Assist Reprod. 2024 Aug 26;28(3):424-429. doi: 10.5935/1518-0557.20240021.
10
Human umbilical cord mesenchymal stem cells improve uterine incision healing after cesarean delivery in rats by modulating the TGF-β/Smad signaling pathway.人脐带间充质干细胞通过调节 TGF-β/Smad 信号通路改善剖宫产大鼠子宫切口愈合。
Arch Gynecol Obstet. 2024 Jul;310(1):103-111. doi: 10.1007/s00404-024-07381-w. Epub 2024 Feb 11.